Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview

J M Kern1, V Maass, M Maass

  • 1Institute of Medical Microbiology, Hygiene and Infectious Diseases, University Hospital Salzburg, Salzburg, Austria.

Insights

Chlamydia pneumoniae survives inside host cells, switching between growth and persistence states. This bacterium

Area of Science:

  • Microbiology
  • Pathogenesis
  • Vascular Biology

Background:

  • Chlamydia pneumoniae is an obligate intracellular bacterium with a unique developmental cycle.
  • It establishes a niche within host cells, evading host defenses.
  • The bacterium can transition between replicative and persistent states, contributing to acute and chronic diseases.

Purpose of the Study:

  • To provide an overview of Chlamydia pneumoniae pathomechanisms.
  • To focus on the bacterium's role in chronic vascular infection and atherosclerosis.

Main Methods:

  • Review of existing literature on Chlamydia pneumoniae pathogenesis.
  • Focus on type III secretion system and effector proteins.

Main Results:

  • Chlamydia pneumoniae utilizes host cell-dependent mechanisms for survival and multiplication.
  • The bacterium employs type III secretion to release effector proteins, reprogramming host cell pathways.
  • Mechanisms facilitating chronic vascular infection remain under investigation.

Conclusions:

  • Chlamydia pneumoniae's intracellular niche and developmental plasticity contribute to its pathogenicity.
  • Understanding its pathomechanisms is crucial for addressing chronic vascular diseases like atherosclerosis.
  • Further research is needed to elucidate the enigmatic link between chronic C. pneumoniae infection and atherosclerosis.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: